Apr 172011

Overt vancomycin resistance in MRSA is still unusual, but ID docs are worried about the bug's rising minimum inhibitory concentrations in some regions, with MICs > 1 mcg/mL associated with worse outcomes. Kullar et al retrospectively looked at Detroit's Henry Ford Hospital's 5-year micro data in 320 patients with MRSA bacteremia, reporting a 52% rate of vancomycin treatment failure. Vanco MIC > 1 had an odds ratio of 1.5 for treatment failure. They suggest targeting high troughs of 15-20 mg/mL and/or the more complex pharmacokinetic calculation, the 24-hour-area-under-the-curve-to-MIC (24-hr AUC/MIC) > 421. Clin Infect Dis 2011;52:975-981.

Liked this post? Get a weekly email update, and explore our library of clinical guidelines, practice updatesreview articles. and board review questions.

PulmCCM is an independent publication not affiliated with or endorsed by any other organization, society or journal referenced on the website. (Terms of Use | Privacy Policy)

Authors: contribute your work in a guest post.


Creepy … MRSA’s “MIC creep” to vancomycin portends worse outcomes